Stanford Medicine News
Precision Health
Read about Stanford Medicine's vision for leading the biomedical revolution.
-
Progress, priorities, challenges are focus of State of Stanford Medicine
At this year’s State of Stanford Medicine event, the dean, hospital CEOs and a special guest shared their reflections on the strengths and challenges of the medical center today.
-
Technologies started at Stanford Biodesign have reached more than 1.5 million patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
-
‘Liquid biopsy’ predicts lymphoma therapy success within days
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
-
Researchers can forecast risk of deadly vascular condition from genome sequence
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
-
Solar-powered heart: Stanford scientists explore using photosynthesis to help damaged hearts
In the ongoing hunt to find better treatments for heart disease, the top cause of death globally, new research from Stanford shows promising results using an unusual strategy: photosynthetic bacteria and light.
-
Researchers identify biomarkers associated with chronic fatigue syndrome severity
Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
-
Virtual reality system helps surgeons, reassures patients
Stanford Medicine is using a new software system that combines imaging from MRIs, CT scans and angiograms to create a three-dimensional model that physicians and patients can see and manipulate — just like a virtual reality game.
-
Jeffrey and Marieke Rothschild gift establishes Stanford Center for Cancer Cell Therapy
The Stanford Cancer Institute has received a $10 million gift from Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, to advance research in cancer cell therapy, which is considered the vanguard of cancer treatment today.
-
Stanford's new Center for Health Education could benefit learners worldwide
With its newly established Center, Stanford seeks to improve global health through a new online medical training initiative for people of all skill levels. Charles Prober, MD, the medical school’s former senior associate dean for medical education, is the founding director.
-
Spencer Center for vision research established at Stanford
Mary M. and Sash A. Spencer's philanthropic gift has created a center to help accelerate translational research, recruit faculty, and train the next generation of leaders in vision science.
-
Philanthropic funding to Stanford Medicine supports record high recruitment and diversity among incoming bioscience graduate students
The School of Medicine has set records in its recruitment statistics for doctoral students this year following the implementation of the Biomedical Innovation Initiative, a funding model that encourages graduate students to follow their passion and take risks.
-
Scientists assemble working human forebrain circuits in a lab dish
Stanford University School of Medicine researchers have observed stem-cell-derived nerve cells arising in a specific region of the human brain migrate into another brain region. This process recapitulates what’s been believed to occur in a developing fetus, but has never previously been viewed in real time.
-
Study shows protein in human umbilical cord blood rejuvenates old mice’s impaired learning, memory
Human umbilical cord blood can rejuvenate learning and memory in older mice, according to a study by researchers at the Stanford University School of Medicine.
-
Deisseroth to receive Harvey Prize in Human Health
The Harvey Prize, established by industrialist and inventor Leo Harvey, recognizes researchers who have made breakthroughs in science and technology of benefit to humanity. Optogenetics has “revolutionized neurobiology,” the prize administrators wrote.
-
Wearable sensors can tell when you are getting sick
New research from Stanford professor and chair of genetics, Michael Snyder, PhD shows that fitness monitors and other wearable biosensors can tell when an individual’s heart rate, skin temperature and other measures are abnormal, suggesting possible illness before it occurs. The results of Snyder’s current study raises the possibility of identifying inflammatory disease in individuals who may not even know they are getting sick.
-
Deep-learning algorithm matches dermatologists’ ability to identify skin cancer
Universal access to health care was on the minds of computer scientists at Stanford when they set out to create an artificially intelligent diagnosis algorithm for skin cancer. They created a database of nearly 130,000 skin disease images and trained the algorithm to visually diagnose potential cancer. From the very first test, it performed with inspiring accuracy.
-
5 Questions: David Entwistle on taking the helm of SHC
In a Q&A, the new president and CEO of Stanford Health Care shares his thoughts about his new job and the evolving health care landscape.
-
Stanford part of Bay Area Biohub collaboration for health research
Stanford will be one of three Bay Area universities — along with the University of California-San Francisco and the University of California-Berkeley — to participate in a new bioscience collaboration funded through a $600 million commitment by the Chan Zuckerberg Initiative.
-
Stanford Cancer Institute Earns Top Cancer Center Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
-
Parker Institute for Cancer Immunotherapy
The new Parker Institute for Cancer Immunotherapy at Stanford Medicine was founded with a $250 million grant from the Parker Foundation. Learn more about their work.
